drugset / Trial / NCT02332031
Sorafenib Drug Drug Interaction Study in Healthy Male Subjects
Non-randomizedSingle-groupOpen-label
Summary
To evaluate the effect of levothyroxine on the absorption, distribution, metabolization and elimination of sorafenib and safety in healthy male subjects
Timeline
- Start
- 2015-02
- Primary completion
- 2015-06
- Completion
- 2015-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levothyroxine | Other / unclassified | 300 ug | Oral |
| Subject | Sorafenib | Small molecule | 400 mg | Oral |
Indications
No indication recorded.